Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Spero Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get SPRO alerts

About Timothy Keutzer

Timothy Keutzer is recorded as COO at Spero Therapeutics, Inc. (SPRO). The newest filing on record that lists Timothy Keutzer as COO at Spero Therapeutics, Inc. (SPRO) is dated April 28, 2025. Spero Therapeutics, Inc. reported in an 8-K filed February 1, 2023 that Timothy Keutzer was appointed Chief Operating Officer, effective February 1, 2023. The proxy statement of Spero Therapeutics, Inc. reports total compensation of $1,438,569 for Timothy Keutzer in fiscal 2023, including a base salary of $456,167. Disclosed compensation is on record for 2 fiscal years. Timothy Keutzer has spoken on 1 earnings call across 1 company, most recently for Spero Therapeutics, Inc. on August 12, 2025. Spero Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spero Therapeutics, Inc. includes Esther Rajavelu (CEO, CFO and Board Member), Ankit Mahadevia, M.D. (Chairman), Frank E. Thomas (Chairman) and 7 others.

“On January 30, 2023, the Board of Directors (the “Board”) of Spero Therapeutics, Inc. (the “Company”) appointed Timothy Keutzer as the Company’s Chief Operating Officer, effective as of February 1, 2023 (the “Effective Date”).”
Spero Therapeutics, Inc. Form 8-K, filed February 1, 2023 · Read the filing

Timothy Keutzer on recent calls

“We estimate that there are approximately 2.9 million episodes of complicated urinary tract infections each year in the United States alone.”
COO, Spero Therapeutics, Inc. Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Spero Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Spero Therapeutics, Inc. (SPRO) $456,167 $1,438,569
2022 Spero Therapeutics, Inc. (SPRO) $423,750 $1,585,037

Recent activity